Singapore, Singapore

Monica Suryana Tjin

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: National University of Singapore, Singapore Health Services Pte Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica Suryana Tjin. Retrieved from https://idiyas.com/inventor/monica-suryana-tjin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monica Suryana Tjin: Innovator in Human Keratinocyte Culture

Introduction

Monica Suryana Tjin is a prominent inventor based in Singapore, known for her significant contributions to the field of cell culture. She has developed innovative methods for culturing human epidermal keratinocytes, which are crucial for various medical applications.

Latest Patents

Monica holds 1 patent titled "Methods for culturing human keratinocytes." This patent describes techniques for culturing keratinocytes on plates coated with laminin containing an alpha-4 chain or an alpha-5 chain, using a xeno-free, chemically defined cell culture medium. The methods allow for efficient in vitro expansion of keratinocytes, which can be utilized in treatments for burns and chronic wounds.

Career Highlights

Throughout her career, Monica has worked with esteemed institutions such as the National University of Singapore and Singapore Health Services Pte Ltd. Her work has had a significant impact on the field of regenerative medicine and tissue engineering.

Collaborations

Monica has collaborated with notable colleagues, including Karl Kristian Tryggvason and Alvin Wen Choong Chua, contributing to advancements in her area of expertise.

Conclusion

Monica Suryana Tjin's innovative work in culturing human keratinocytes showcases her dedication to improving medical treatments and advancing scientific knowledge. Her contributions are invaluable to the field of regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…